KR
Insider
Kathryn Romano
Chief Accounting OfficerKathryn Romano (Chief Accounting Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Krystal Biotech, Inc. (KRYS). The largest single filing was $3.4M of KRYS (12,404 sh across 6 lots, as filed), executed Feb 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.6M
shares × price, as filed
Last traded
Mar 2
Filed Mar 3
Median ADV $140.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KRYSRecent filings
KRYSSALE
Krystal Biotech, Inc.
View filing →
$201K750 sh × $267.60
Exec Mar 2
Filed Mar 3 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $3.4M
12,404 sh across 6 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET KRYSSALE Krystal Biotech, Inc. View filing → $131K
750 sh × $175.22
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET